Syncona

Syncona Syncona is not a typical VC. it's a FTSE250-listed company that founds, builds, and funds transformational healthcare companies, with a biotech portfolio valued at £1.2B. The public listing creates an unusual dynamic: shares trade at roughly a 45% discount to net asset value (market cap ~£659M), which means public market investors are effectively getting the portfolio at half price. In 2024/25, Syncona deployed £135.3M into its portfolio while companies raised an additional £175.5M exte